Anna R. Duca
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Pharmacology top 2%
- Treatment of Major Depression
Papers in
-
- Schizophrenia research and treatment 4
- Electroconvulsive Therapy Studies 1
- Bipolar Disorder and Treatment 1
-
- Treatment of Major Depression 2
- Co-authors
- Timothy S. Peters-Strickland (4 shared papers)Ross A. Baker (3 shared papers)Raymond E.A. Sanchez (3 shared papers)Robert D. McQuade (4 shared papers)Anna Eramo (4 shared papers)Brian R. Johnson (3 shared papers)John Michael Kane (2 shared papers)Joan Liu Zhao (1 shared paper)
- Journals
- European Neuropsychopharmacology (2 papers)Journal of Medical Economics (2 papers)The Lancet Infectious Diseases (1 paper)JAMA Psychiatry (1 paper)Schizophrenia (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Anna R. Duca
7 papers receiving 616 citations
Anna R. Duca's Hit Papers
Peers
Comparison fields: 5 of 66
- Biological Psychiatry 182
- Pharmacology 366
- Psychiatry and Mental health 147
- Behavioral Neuroscience 27
- Cellular and Molecular Neuroscience 79
Countries citing papers authored by Anna R. Duca
This map shows the geographic impact of Anna R. Duca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna R. Duca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna R. Duca more than expected).
Fields of papers citing papers by Anna R. Duca
This network shows the impact of papers produced by Anna R. Duca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna R. Duca. The network helps show where Anna R. Duca may publish in the future.
Co-authors
The 13 scholars most cited alongside Anna R. Duca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2019 | 469 |
| 2 | 2022 | 65 | |
| 3 | 2014 | 43 | |
| 4 | 2013 | 41 | |
| 5 | 2015 | 12 | |
| 6 | 2014 | 1 | |
| 7 | 2019 | 1 |
About Anna R. Duca
Anna R. Duca is a scholar working on Psychiatry and Mental health, Pharmacology, Clinical Psychology, Infectious Diseases and Insect Science, having authored 7 papers that have together received 632 indexed citations. Recurring topics across this work include Schizophrenia research and treatment (4 papers), Treatment of Major Depression (2 papers), Electroconvulsive Therapy Studies (1 paper), Perfectionism, Procrastination, Anxiety Studies (1 paper), Child and Adolescent Psychosocial and Emotional Development (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Bipolar Disorder and Treatment (1 paper). The work is most often cited by research in Biological Psychiatry (182 citations), Pharmacology (366 citations), Psychiatry and Mental health (147 citations), Behavioral Neuroscience (27 citations) and Cellular and Molecular Neuroscience (79 citations). Anna R. Duca has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Timothy S. Peters-Strickland, Ross A. Baker, Raymond E.A. Sanchez, Robert D. McQuade, Anna Eramo, Brian R. Johnson, John Michael Kane, Joan Liu Zhao, Cathy Yunjia Zhao and Pamela P. Perry. Their work appears in journals such as European Neuropsychopharmacology, Journal of Medical Economics, The Lancet Infectious Diseases, JAMA Psychiatry and Schizophrenia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.